|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Research and development expenses | |
| General and administrative expenses | |
| Total operating expenses | |
| Other operating income | |
| Operating loss | |
| Changes in fair value of financial liabilities | |
| Financial expenses | |
| Financial income | |
| Loss before taxes | |
| Loss for the year | |
| Weighted average number of common shares outstanding, Basic | |
| Weighted average number of common shares outstanding, Diluted | |
| Basic loss per share (in €) | |
| Diluted loss per share (in €) |
Loading...
